PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 69 filers reported holding PDS BIOTECHNOLOGY CORP in Q1 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,670,192 | -53.4% | 271,576 | 0.0% | 0.01% | -53.8% |
| Q4 2022 | $3,584,803 | +344.8% | 271,576 | 0.0% | 0.01% | +333.3% |
| Q3 2022 | $806,000 | -18.7% | 271,576 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $991,000 | -41.0% | 271,576 | 0.0% | 0.00% | -20.0% |
| Q1 2022 | $1,681,000 | -23.6% | 271,576 | 0.0% | 0.01% | -28.6% |
| Q4 2021 | $2,199,000 | -24.6% | 271,576 | +38.7% | 0.01% | -36.4% |
| Q3 2021 | $2,917,000 | +34.4% | 195,819 | +13.2% | 0.01% | +37.5% |
| Q2 2021 | $2,170,000 | +220.1% | 172,931 | +16.0% | 0.01% | +166.7% |
| Q1 2021 | $678,000 | +112.5% | 149,067 | 0.0% | 0.00% | +50.0% |
| Q4 2020 | $319,000 | -8.1% | 149,067 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $347,000 | +16.1% | 149,067 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $299,000 | +176.9% | 149,067 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $108,000 | – | 149,067 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 117,242 | $311,000 | 0.07% |
| Andesa Financial Management Inc. | 16,655 | $44,000 | 0.04% |
| Sofinnova Investments, Inc. | 142,635 | $378,000 | 0.03% |
| INSPIRION WEALTH ADVISORS, LLC | 22,875 | $61,000 | 0.02% |
| REGENTATLANTIC CAPITAL LLC | 15,753 | $42,000 | 0.00% |
| Ellis Investment Partners, LLC | 2,250 | $5,000 | 0.00% |
| tru Independence LLC | 500 | $0 | 0.00% |
| Renaissance Technologies | 120,269 | $319,000 | 0.00% |
| D. E. Shaw & Co., Inc. | 13,281 | $35,000 | 0.00% |
| VANGUARD GROUP INC | 36,206 | $96,000 | 0.00% |